Compare MCW & BCRX Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
| Metric | MCW | BCRX |
|---|---|---|
| Founded | 1996 | 1986 |
| Country | United States | United States |
| Employees | N/A | N/A |
| Industry | | Biotechnology: Biological Products (No Diagnostic Substances) |
| Sector | | Health Care |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 2.3B | 2.3B |
| IPO Year | 2021 | 1995 |
| Metric | MCW | BCRX |
|---|---|---|
| Price | $7.11 | $8.88 |
| Analyst Decision | Hold | Strong Buy |
| Analyst Count | 11 | 11 |
| Target Price | $7.28 | ★ $20.82 |
| AVG Volume (30 Days) | ★ 5.6M | 4.7M |
| Earning Date | 04-29-2026 | 05-06-2026 |
| Dividend Yield | N/A | N/A |
| EPS Growth | 47.62 | ★ 381.40 |
| EPS | ★ 0.10 | N/A |
| Revenue | ★ $1,051,731,000.00 | $25,186,000.00 |
| Revenue This Year | $7.92 | N/A |
| Revenue Next Year | $7.05 | $12.55 |
| P/E Ratio | $71.10 | ★ N/A |
| Revenue Growth | ★ 5.73 | N/A |
| 52 Week Low | $4.61 | $6.00 |
| 52 Week High | $7.16 | $11.31 |
| Indicator | MCW | BCRX |
|---|---|---|
| Relative Strength Index (RSI) | 67.52 | 49.90 |
| Support Level | $7.01 | $8.89 |
| Resistance Level | $7.14 | $10.04 |
| Average True Range (ATR) | 0.04 | 0.42 |
| MACD | 0.00 | 0.01 |
| Stochastic Oscillator | 68.97 | 47.08 |
Mister Car Wash Inc is a car wash brand offering express exterior and interior cleaning services. The company's car wash locations consist of two formats: Express Exterior Locations and Interior Cleaning Locations. Express Exterior Locations offer self-drive exterior cleaning services and include free vacuums available for customer use. Interior Cleaning Locations offer exterior and interior cleaning services, including vacuuming. The company recognizes revenue from activities related to providing car wash services at its car wash locations that are geographically diversified throughout the United States and have similar economic characteristics and nature of services.
BioCryst Pharmaceuticals Inc is a biotechnology company involved mainly in the research and development of novel small-molecule drugs, to block key enzymes involved in infectious and inflammatory diseases. Biocryst's research is based on multiple scientific disciplines like biology, computer modeling, and medicinal chemistry. Its products and candidates target the following therapeutic areas: acute uncomplicated influenza; uncomplicated seasonal influenza; hereditary angioedema; filoviruses, including the Ebola and Marburg viruses; and oncology.